scispace - formally typeset
T

Terho Lehtimäki

Researcher at University of Tampere

Publications -  1375
Citations -  129159

Terho Lehtimäki is an academic researcher from University of Tampere. The author has contributed to research in topics: Population & Genome-wide association study. The author has an hindex of 142, co-authored 1304 publications receiving 106981 citations. Previous affiliations of Terho Lehtimäki include Boston University & National Institutes of Health.

Papers
More filters

Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations

Phuwanat Sakornsakolpat, +155 more
TL;DR: Genome-wide analysis of chronic obstructive pulmonary disease identifies 82 loci, 35 of which are new, and integrates gene expression and genomic annotation data shows enrichment of signals in lung tissue, smooth muscle and several lung cell types.
Journal ArticleDOI

FTO genetic variants, dietary intake and body mass index: insights from 177 330 individuals

Qibin Qi, +110 more
TL;DR: A positive association between the BMI-increasing allele of FTO variant and higher dietary protein intake is suggested and insight is offered into potential link between FTO, dietaryprotein intake and adiposity.
Journal ArticleDOI

Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer's disease: A prospective study in eight cohorts

TL;DR: In this article, the authors studied eight prospective cohorts with 22,623 participants profiled by nuclear magnetic resonance or mass spectrometry metabolomics and found that three branched-chain amino acids (isoleucine, leucine and valine), creatinine and two very low density lipoprotein (VLDL)-specific lipid subclasses were associated with lower dementia risk.

Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk

Helen R. Warren, +267 more
TL;DR: Results from genetic risk score models raise the possibility of a precision medicine approach through early lifestyle intervention to offset the impact of blood pressure–raising genetic variants on future cardiovascular disease risk.